11 March 2021

 

 

LSP is excited to announce BioCapital Europe will be a digital-only event for 2021. Due to the current COVID-19 pandemic, BioCapital will be using best-in-class digital event technology to deliver everything you have come to know from BioCapital from the comfort of your home or office.

Register here 

 

2021 Programme

10th March – Pre-Conference Event

18:00 – The changing landscape of Alzheimer’s disease and dementia: reasons to be optimistic!

18:30 – Shaping the new Biotech reality – Key lessons from COVID.
              Moderator: Alessandra Abate, Managing Director, Russell Reynolds Associates
             Panelists: Chris Maggos, Managing Director, Head of Europe, LifeSci Advisors
                              Berndt Modig, CEO, Pharvaris
                              Dana Krueger, Global Healthcare, Russell Reynolds Associates
                              Sean Marett, Chief Business Officer & Chief Commercial Officer, BioNTech
                              Arthur Lahr, CEO, Kiadis
                              Geraldine O’Keeffe, Partner, LSP

 

11th March – Opening Ceremony

8:50 – Opening Remarks: Dr René R. Kuijten, Managing Partner LSP

Keynote Presentations

9:00 – Keynote: Sam Fazeli, Director of EMEA Research, Senior Pharmaceutical Analyst of Bloomberg Intelligence
13:30 – Keynote: Brian Rye, Senior Analyst Healthcare Policy, Bloomberg

Panels

12:30 – Panel Session: The road to Nasdaq
Eduardo Bravo, Jan de Kerpel moderated by Mark Wegter
13:00 – Panel Session: Public equity markets present exciting opportunities for healthcare investors
Sam Fazeli and Mark Wegter

Early Stage Therapeutics – Private Track

09:30 – Celon
09:50 – Nouscom (IT)
10:10 – Vaximm
10:30 – Aelin Therapeutics (BE)
10:50 – Binx Health
11:10 – AM-Pharma (NL)
11:30 – Vico Therapeutics (BE)
11:50 – ImCheck Therapeutics (FR)
12:10 – Cardior (DE)
14:10 – eTheRNA (BE)
14:30 – SNIPR Biome (DK)
14:50 – Imcyse (BE)
15:10 – Amolyt Pharma (FR)
15:30 – New Amsterdam Pharma (NL)
15:50 – FoRx Therapeutics (CH)
16:10 – OxThera (SE)
16:30 – ISA Pharma (NL)
16:50 – XyloCor Therapeutics (US)
17:10 – EIP Pharma (US)

MedTech

9:30 – Vicentra (NL)
9:50 – ONWARD (NL)
10:30 – Xeltis (NL)
10:50 – Venari Medical (IE)
11:10 – LimFlow (FR)
11:30 – iStar Medical (BE)
11:50 – Neurent Medical (IE)
12:10 – Vivasure Medical (IE)
14:10 – Cardiawave (FR)
14:30 – OneProjects (IE)
14:50 – DNA Script (FR)
15:10 – Cergentis (NL)
15:30 – Atlantic Therapeutics (IE)
16:10 – Sequana Medical (CH)

Late Stage Therapeutics – Public Track

09:30 – Hyloris (BE)
09:50 – Evotec (DE)
10:10 – Galapagos (NL)
10:30 – Pharming Group (NL)
10:50 – Immunic (US)
11:10 – Mithra (BE)
11:30 – Kuros (CH)
11:50 – Calliditas (SE)
12:10 – Kiadis (NL)
14:10 – Orphazyme (DK)
14:30 – Vivoryon Therapeutics (DE)
14:50 – Pharvaris (NL)
15:10 – Heidelberg Pharma (DE)
15:30 – Merus (NL)
15:50 – Celyad Oncology (BE)
16:10 – Oryzon (ES)
16:30 – Oncopeptides (SE)
16:50 – Eloxx (US)

 

Conference Overview

BioCapital Europe 2021, organised by LSP is delighted to announce its 18th consecutive event, taking place on 11th March 2021 using a best-in-class digital platform. Due to the current state of COVID-19 around the world, BioCapital Europe will be a digital only event, enabling you to access everything BioCapital has to offer from the comfort of your home or office.

BioCapital Europe 2021, will offer you the opportunity to access all presentations digitally both live and on-demand, as well offering you the same networking opportunities through leading virtual event technology.

BioCapital Europe is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe. In 2019, the event attracted over 250 attendees (mainly CEOs, CFOs, pharma execs, VCs, and Institutional Investors). VCs and Institutional Investors are invited to attend free of charge to this event.

Sponsors 2021